AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

CORCEPT THERAPEUTICS INC Director's Dealing 2011

Sep 12, 2011

30681_dirs_2011-09-12_2e3f1393-f8e1-4c55-80fc-220cda3bfbdc.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2011-09-01

Reporting Person: Robb Gary Charles (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1258	Direct